Seeing Is Believing
Currently out of the existing stock ratings of Kemp Dolliver, 5 are a BUY (83.33%), 1 are a HOLD (16.67%).
Analyst Kemp Dolliver works at BROOKLINE with a stock forecast success ratio of 8.33% fulfilled within 1.25 days on average.
Kemp Dolliver’s has documented 12 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PNT, POINT Biopharma Global at 21-Dec-2023.
Analyst best performing recommendations are on PNT (POINT BIOPHARMA GLOBAL).
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
15
$8.91 (146.31%)
11
2 months 5 days ago
1/7 (14.29%)
$7.77 (107.47%)
318
Buy
1.25
$-5.56 (-81.64%)
1 years 2 months 14 days ago
0/1 (0%)
$-3.28 (-72.41%)
Which stock is Kemp Dolliver is most bullish on?
Which stock is Kemp Dolliver is most reserved on?
What Year was the first public recommendation made by Kemp Dolliver?